The regulation of long non-coding RNA 00958 (LINC00958) for oral squamous cell carcinoma (OSCC) cells death through absent in melanoma 2 (AIM2) depending on microRNA-4306 and Sirtuin1 (SIRT1) in vitro

References

• Lee CE, Vincent-Chong VK, Ramanathan A, et al. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications. Int J Med Sci. 2015;12(12):937–945.
   PubMed Web of Science ®Google Scholar
• Marsh D, Suchak K, Moutasim KA. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol. 2011;223(4):470–481.
   PubMed Web of Science ®Google Scholar
• Guo G, Kang Q, Zhu X, et al. A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA. Oncogene. 2015;34(14):1768–1779.
   PubMed Web of Science ®Google Scholar
• Wang L, Ge S, Zhou F. MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A. Bioengineered. 2021;12(1):937–947.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhu Q, Lu L, et al. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020;11(1):91–102.
   PubMed Web of Science ®Google Scholar
• He S, Zhang W, Li X, et al. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation. Bioengineered. 2021;12(1):2164–2174.
   PubMed Web of Science ®Google Scholar
• Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA [published correction appears in Cell. 2011 Nov 11;147(4):947]. Cell. 2011;147(2):358–369.
   Google Scholar
• Seitz AK, Christensen LL, Christensen E, et al. Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer. Sci Rep. 2017;7(1):395.
   PubMedGoogle Scholar
• Chen F, Liu M, Yu Y, et al. LINC00958 regulated miR-627-5p/YBX2 axis to facilitate cell proliferation and migration in oral squamous cell carcinoma. Cancer Biol Ther. 2019;20(9):1270–1280.
   PubMed Web of Science ®Google Scholar
• Zuo X, Chen Z, Gao W, et al. M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. J Hematol Oncol. 2020;13(1):5.
   Google Scholar
• Wang L, Zhong Y, Yang B, et al. LINC00958 facilitates cervical cancer cell proliferation and metastasis by sponging miR-625-5p to upregulate LRRC8E expression. J Cell Biochem. 2020;121(3):2500–2509.
   PubMed Web of Science ®Google Scholar
• Chen M, Xu Z, Zhang Y, et al. LINC00958 promotes the malignancy of nasopharyngeal carcinoma by sponging microRNA-625 and thus upregulating NUAK1. Onco Targets Ther. 2019;12:9277–9290.
   PubMed Web of Science ®Google Scholar
• Chen S, Chen J-Z, Zhang J-Q, et al. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8. Cancer Lett. 2019;446:49–61.
   PubMed Web of Science ®Google Scholar
• Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics. 2009;7(4):147–154.
   PubMedGoogle Scholar
• Brooks CL, Gu W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer. 2009;9(2):123–128.
   PubMed Web of Science ®Google Scholar
• Islam S, Uehara O, Matsuoka H, et al. DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing-a possible predictive biomarker for malignant transformation. Clin Epigenetics. 2020;12(1):12.
   PubMed Web of Science ®Google Scholar
• Chen IC, Chiang WF, Huang HH, Chen PF, Shen YY, Chiang HC. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Mol Cancer. 2014;13:254.
   Google Scholar
• Hida Y, Kubo Y, Murao K, et al. Strong expression of a longevity-related protein, SIRT1, in Bowen’s disease. Arch Dermatol Res. 2007;299(2):103–106.
   PubMed Web of Science ®Google Scholar
• Kang YY, Sun FL, Zhang Y, Wang Z. SIRT1 acts as a potential tumor suppressor in oral squamous cell carcinoma. J Chin Med Assoc. 2018;81(5):416–422.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Auh QS, Lee YM, et al. Growth inhibition and apoptosis-inducing effects of cudraflavone B in human oral cancer cells via MAPK, NF-κB, and SIRT1 signaling pathway. Planta Med. 2013;79(14):1298–1306.
   PubMed Web of Science ®Google Scholar
• Jianyuan et al. negative control of p53 by sir2alpha promotes cell survival under stress.
   Google Scholar
• Jung-Hynes B, Ahmad N. Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells. Cell Cycle. 2009;8(10):1478–1483.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Nagai K, Nakahata S, et al. Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation. Cancer Sci. 2012;103(4):782–790.
   PubMed Web of Science ®Google Scholar
• Prasad KS, Cao X, Gao N, et al. A Low-cost nanomaterial-based electrochemical immunosensor on paper for high-sensitivity early detection of pancreatic cancer. Sensors & Actuators B: Chem. 2020;305:127516.
   PubMed Web of Science ®Google Scholar
• Low SS, Pan Y, Ji D, et al. Smartphone-based portable electrochemical biosensing system for detection of circulating microRNA-21 in saliva as a proof-of-concept. Sensors &Actuators B Chem. 308:127718.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Kiguchi T, Kakihara Y, Yamazaki M, et al. Identification and characterization of R2TP in the development of oral squamous cell carcinoma. Biochem Biophys Res Commun. 2021;548:161–166.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Nakahata S, Kondo Y, et al. Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression. Biochem Biophys Res Commun. 2019;509(1):82–88.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zhu Y, He Z, et al. Long Non-Coding RNA Expression Profile Associated with Malignant Progression of Oral Submucous Fibrosis. J Oncol. 2019;2019:6835176.
   PubMed Web of Science ®Google Scholar
• Zhou G, Liu Z, Myers JN. TP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response. J Cell Biochem. 2016;117(12):2682–2692.
   PubMed Web of Science ®Google Scholar
• García-Carracedo D, Cai Y, Qiu W, et al. PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice. Mol Cancer Res. 2020;18(6):822–834.
   Google Scholar
• Yang B, Chen Z, Huang Y, Han G, Li W. Identification of potential biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma by bioinformatics analysis. Onco Targets Ther. 2017;10:2315–2321.
   Google Scholar
• Lin F, Gao L, Su Z, et al. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation. Oncol Rep. 2018;40(1):179–194.
   PubMed Web of Science ®Google Scholar
• Irimie AI, Braicu C, Pileczki V, et al. Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells. Mol Cell Biochem. 2016;419(1–2):75–82.
   PubMed Web of Science ®Google Scholar
• Ou L, Sun T, Liu M, et al. Efficient miRNA inhibitor delivery with graphene oxide-polyethylenimine to inhibit oral squamous cell carcinoma. Int J Nanomedicine. 2020;15:1569–1583.
   PubMed Web of Science ®Google Scholar
• Huang X, Wu Z, Mei Y, Wu M. XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling. EMBO J. 2013;32(16):2204–2216.
   PubMed Web of Science ®Google Scholar
• Jiang P, Du W, Heese K, et al. The Bad guy cooperates with good cop p53: bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol Cell Biol. 2006;26(23):9071–9082.
   PubMed Web of Science ®Google Scholar
• Bi L, Yan X, Chen W, et al. Antihepatocellular carcinoma potential of tetramethylpyrazine induces cell cycle modulation and mitochondrial-dependent apoptosis: regulation of p53 signaling pathway in HepG2 cells in vitro. Integr Cancer Ther. 2016;15(2):226–236.
   PubMed Web of Science ®Google Scholar
• Chen KW, Demarco B, Broz P. Beyond inflammasomes: emerging function of gasdermins during apoptosis and NETosis. EMBO J. 2020;39(2):e103397.
   Google Scholar
• Deswaerte V, Nguyen P, West A, et al. Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism. Cancer Res. 2018;78(5):1293.
   PubMed Web of Science ®Google Scholar
• Ruhl S, Shkarina K, Demarco B, et al. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018;362(6417):956–960.
   PubMed Web of Science ®Google Scholar
• Carty M, Kearney J, Shanahan KA, et al. Cell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARM. Immunity. 2019;50(6):1412–1424.e1416.
   PubMed Web of Science ®Google Scholar